
Teva Pharmaceuticals announces an exclusive launch of a generic version of atazanavir capsules for the treatment of HIV.

Teva Pharmaceuticals announces an exclusive launch of a generic version of atazanavir capsules for the treatment of HIV.

According to a new study, when combatting viruses such as HIV, several enzymes in the immune system may malfunction and cause cancer-related mutations.

The FDA approved the administration of Isentress HD in patients weighing at least 40-kg who are treatment-naïve or who achieved viral suppression from treatment with raltegravir.

Researchers found that HCV infection may be linked to more cancers besides hepatocellular carcinoma, as well as certain types of non-Hodgkin lymphoma.

Published: February 16th 2017 | Updated:

Published: June 1st 2017 | Updated:

Published: December 29th 2017 | Updated:

Published: January 15th 2018 | Updated: